Synonym
Ethnor; Absele; Respren
IUPAC/Chemical Name
1H-Imidazole-5-carboxylic acid, 1-(1-phenylethyl)-, ethyl ester, (+-)-
InChi Key
NPUKDXXFDDZOKR-UHFFFAOYSA-N
InChi Code
InChI=1S/C14H16N2O2/c1-3-18-14(17)13-9-15-10-16(13)11(2)12-7-5-4-6-8-12/h4-11H,3H2,1-2H3
SMILES Code
O=C(C1=CN=CN1C(C2=CC=CC=C2)C)OCC
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
244.29
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Ruhatiya OK. Exacerbation of myasthenia gravis by single dose of Respren (Ethnor) and Astemizole tablets. J Assoc Physicians India. 1993 May;41(5):316. PubMed PMID: 8300478.
2: Schoenenberger A, Mettler D, Roesler H, Zimmermann A, Bilweis J, Schilt W, Zingg EJ. Surgical repair of the kidney after blunt lesions of intermediate degree using a Vicryl mesh: an experimental study. J Urol. 1985 Oct;134(4):804-8. PubMed PMID: 3875735.
3: Meyer BH, Hugo JM. Etomidate as anaesthetic induction agent in open-heart surgery. S Afr Med J. 1980 Nov 8;58(19):759-61. PubMed PMID: 6999642.
4: Klemp P, Meyers OL. Clinical trial of tolmetin and aspirin in the treatment of rheumatoid arthritis. S Afr Med J. 1977 Jul 23;52(5):167-9. PubMed PMID: 331504.
5: Barbezat GO, Clain JE, Halter F. A double-blind trial of loperamide in the treatment of chronic diarrhoea. S Afr Med J. 1979 Mar 24;55(13):502-3. PubMed PMID: 377521.
6: Kayser HJ. Treatment of hydatid disease with mebendazole at Frere Hospital, East London. A preliminary report. S Afr Med J. 1980 Oct 4;58(14):560-3. PubMed PMID: 7423294.
7: Müller FO, Gosling JA, Erdmann GH. A comparison of tolmetin with aspirin in the treatment of osteo-arthritis of the knee. S Afr Med J. 1977 May 28;51(22):794-6. PubMed PMID: 327585.
8: Van Eeden AF, Leiman BC. Hypnosis with etomidate during total intravenous anaesthesia. S Afr Med J. 1980 Dec 20;58(25):1002-4. PubMed PMID: 7003771.
9: Adamsbaum C, Leclet H, Kalifa G. Intralesional Ethibloc Injections in Bone Cysts. Semin Musculoskelet Radiol. 1997;1(2):301-304. PubMed PMID: 11387080.
10: Cristalli BG, Izard V, Jacob D, Levardon M. Laparoscopic appendectomy using a clip applier. Surg Endosc. 1991;5(4):176-8. PubMed PMID: 1839575.
11: Cottalorda J, Kohler R, Chotel F, de Gauzy JS, Lefort G, Louahem D, Bourelle S, Diméglio A. Recurrence of aneurysmal bone cysts in young children: a multicentre study. J Pediatr Orthop B. 2005 May;14(3):212-8. PubMed PMID: 15812295.
12: Topouchian V, Mazda K, Hamze B, Laredo JD, Penneçot GF. Aneurysmal bone cysts in children: complications of fibrosing agent injection. Radiology. 2004 Aug;232(2):522-6. Epub 2004 Jun 23. PubMed PMID: 15215542.
13: Cristalli B, Cayol A, Izard V, Levardon M. [Intra-peritoneal appendectomy by celioscopy. Preliminary results of a new technique]. J Chir (Paris). 1991 Jun-Jul;128(6-7):302-5. French. PubMed PMID: 1832679.
14: Açikgöz B, Ozcan E. The use of bone-chip grafts fixed with absorbable bone sealant (Absele). Paraplegia. 1991 Sep;29(7):486-9. PubMed PMID: 1784516.
15: Köndell PA, Nordenram A, Anneroth G, Mattsson T. Absele in bone hemostasis--a clinical and experimental investigation. Swed Dent J. 1988;12(3):85-90. PubMed PMID: 3043743.
